glucagon

Diabetes obesity weight loss
Biotech

Lilly triple-G bet sees 16.8% weight loss in ph. 3 diabetes test

Eli Lilly is rounding out its pitch for retatrutide with new data looking at blood sugar reductions and weight loss in patients with Type 2 diabetes.
Fraiser Kansteiner Mar 19, 2026 6:45am
Graphic images of white and black puzzle pieces connecting seamlessly

Eli Lilly taps Camurus' tech to advance long-acting obesity meds

Jun 3, 2025 5:04pm